Cancer Pain Management Solutions Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Pain Management Type (Acute Pain Management, Moderate Pain Management, and Severe Pain Management); Treatment Type (Medications, and Devices or Systems); Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, and Others); End Use (Hospitals, Clinics, and Others), and Geography

Report Code: TIPRE00022897 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The Cancer Pain Management Solutions Market is anticipated to gain a telling impetus while riding on the moderate to severe pattern of pain experienced by patients worldwide. Nearly 70% of cancer patients could suffer from chronic pain because of spinal cord injuries, 28% due to multiple sclerosis, and 8% on account of stroke on a global platform. Besides this, above 75% of the patients are expected to complain of a gradual surge in pain with the progression of the disease. Therefore, an increase in the count of patients experiencing such pain could positively affect the growth of the market. Furthermore, with elevating research and development focus, there could be a range of drugs in the pipeline. This is envisaged to bode well for the global cancer pain management market as more drugs could increase demand.

MARKET SCOPE

The "Global Cancer Pain Management Solutions Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cancer pain management solutions market with detailed market segmentation by pain management type, treatment type, disease indication, end use and geography. The report provides key statistics on the market status of the leading cancer pain management solutions market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on pain management type, the global cancer pain management solutions market is segmented into acute pain management, moderate pain management, and severe pain management.
  •  On the basis of treatment type, the market is segmented into medications, and devices or systems. Medications are again segmented into opioids/narcotics, non-opioids, and nerve blocks, and devices is segmented into electrical stimulation devices, analgesic infusion pumps, neurostimulation devices, and radiofrequency ablation devices.
  •  On the basis of disease indication, the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer, and others.
  •  On the basis of end use, the market is segmented into hospitals, clinics, and others.

MARKET DYNAMICS
Drivers

  •  Rise in the incidences of cancer globally.
  •  Growing awareness regarding cancer and its pain management.
  •  Increased healthcare expenditures, increase in government initiatives to alleviate cancer
  •  Surge in geriatric population

Restraints

  •  The adverse effect associated with the use of cancer pain drugs are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cancer pain management solutions market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cancer pain management solutions market in these regions.

IMPACT OF COVID-19 ON CANCER PAIN MANAGEMENT SOLUTIONS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the cancer pain management solutions market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cancer pain management solutions market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer pain management solutions in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cancer pain management solutions market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Teva Pharmaceutical Industries Ltd.
  •  Eli Lilly.
  •  Pfizer
  •  Johnson & Johnson
  •  Purdue Pharma
  •  Endo Pharmaceuticals Plc.
  •  Forest Laboratories Inc.
  •  GlaxoSmithKline Plc.
  •  F. Hoffmann-La Roche Ltd.
  •  Baxter International Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Pain Management Solutions Market - By Pain Management Type
1.3.2 Cancer Pain Management Solutions Market - By Treatment Type
1.3.3 Cancer Pain Management Solutions Market - By Disease Indication
1.3.4 Cancer Pain Management Solutions Market - By End Use
1.3.5 Cancer Pain Management Solutions Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER PAIN MANAGEMENT SOLUTIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER PAIN MANAGEMENT SOLUTIONS - GLOBAL MARKET OVERVIEW
6.2. CANCER PAIN MANAGEMENT SOLUTIONS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2028 - PAIN MANAGEMENT TYPE
7.1. OVERVIEW
7.2. PAIN MANAGEMENT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACUTE PAIN MANAGEMENT
7.3.1. Overview
7.3.2. Acute Pain Management Market Forecast and Analysis
7.4. MODERATE PAIN MANAGEMENT
7.4.1. Overview
7.4.2. Moderate Pain Management Market Forecast and Analysis
7.5. SEVERE PAIN MANAGEMENT
7.5.1. Overview
7.5.2. Severe Pain Management Market Forecast and Analysis
8. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. MEDICATIONS
8.3.1. Overview
8.3.2. Medications Market Forecast and Analysis
8.3.3. Opioids/Narcotics Market
8.3.3.1. Overview
8.3.3.2. Opioids/Narcotics Market Forecast and Analysis
8.3.4. Non-Opioids Market
8.3.4.1. Overview
8.3.4.2. Non-Opioids Market Forecast and Analysis
8.3.5. Nerve Blocks Market
8.3.5.1. Overview
8.3.5.2. Nerve Blocks Market Forecast and Analysis
8.4. DEVICES OR SYSTEMS
8.4.1. Overview
8.4.2. Devices or Systems Market Forecast and Analysis
8.4.3. Electrical Stimulation Devices Market
8.4.3.1. Overview
8.4.3.2. Electrical Stimulation Devices Market Forecast and Analysis
8.4.4. Analgesic Infusion Pumps Market
8.4.4.1. Overview
8.4.4.2. Analgesic Infusion Pumps Market Forecast and Analysis
8.4.5. Neurostimulation Devices Market
8.4.5.1. Overview
8.4.5.2. Neurostimulation Devices Market Forecast and Analysis
8.4.6. Radiofrequency Ablation Devices Market
8.4.6.1. Overview
8.4.6.2. Radiofrequency Ablation Devices Market Forecast and Analysis
9. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
9.1. OVERVIEW
9.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
9.3. LUNG CANCER
9.3.1. Overview
9.3.2. Lung Cancer Market Forecast and Analysis
9.4. COLORECTAL CANCER
9.4.1. Overview
9.4.2. Colorectal Cancer Market Forecast and Analysis
9.5. BREAST CANCER
9.5.1. Overview
9.5.2. Breast Cancer Market Forecast and Analysis
9.6. PROSTATE CANCER
9.6.1. Overview
9.6.2. Prostate Cancer Market Forecast and Analysis
9.7. BLOOD CANCER
9.7.1. Overview
9.7.2. Blood Cancer Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. CANCER PAIN MANAGEMENT SOLUTIONS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
10.1. OVERVIEW
10.2. END USE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. CANCER PAIN MANAGEMENT SOLUTIONS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Cancer Pain Management Solutions Market Overview
11.1.2 North America Cancer Pain Management Solutions Market Forecasts and Analysis
11.1.3 North America Cancer Pain Management Solutions Market Forecasts and Analysis - By Pain Management Type
11.1.4 North America Cancer Pain Management Solutions Market Forecasts and Analysis - By Treatment Type
11.1.5 North America Cancer Pain Management Solutions Market Forecasts and Analysis - By Disease Indication
11.1.6 North America Cancer Pain Management Solutions Market Forecasts and Analysis - By End Use
11.1.7 North America Cancer Pain Management Solutions Market Forecasts and Analysis - By Countries
11.1.7.1 United States Cancer Pain Management Solutions Market
11.1.7.1.1 United States Cancer Pain Management Solutions Market by Pain Management Type
11.1.7.1.2 United States Cancer Pain Management Solutions Market by Treatment Type
11.1.7.1.3 United States Cancer Pain Management Solutions Market by Disease Indication
11.1.7.1.4 United States Cancer Pain Management Solutions Market by End Use
11.1.7.2 Canada Cancer Pain Management Solutions Market
11.1.7.2.1 Canada Cancer Pain Management Solutions Market by Pain Management Type
11.1.7.2.2 Canada Cancer Pain Management Solutions Market by Treatment Type
11.1.7.2.3 Canada Cancer Pain Management Solutions Market by Disease Indication
11.1.7.2.4 Canada Cancer Pain Management Solutions Market by End Use
11.1.7.3 Mexico Cancer Pain Management Solutions Market
11.1.7.3.1 Mexico Cancer Pain Management Solutions Market by Pain Management Type
11.1.7.3.2 Mexico Cancer Pain Management Solutions Market by Treatment Type
11.1.7.3.3 Mexico Cancer Pain Management Solutions Market by Disease Indication
11.1.7.3.4 Mexico Cancer Pain Management Solutions Market by End Use
11.2. EUROPE
11.2.1 Europe Cancer Pain Management Solutions Market Overview
11.2.2 Europe Cancer Pain Management Solutions Market Forecasts and Analysis
11.2.3 Europe Cancer Pain Management Solutions Market Forecasts and Analysis - By Pain Management Type
11.2.4 Europe Cancer Pain Management Solutions Market Forecasts and Analysis - By Treatment Type
11.2.5 Europe Cancer Pain Management Solutions Market Forecasts and Analysis - By Disease Indication
11.2.6 Europe Cancer Pain Management Solutions Market Forecasts and Analysis - By End Use
11.2.7 Europe Cancer Pain Management Solutions Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Cancer Pain Management Solutions Market
11.2.7.1.1 Germany Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.1.2 Germany Cancer Pain Management Solutions Market by Treatment Type
11.2.7.1.3 Germany Cancer Pain Management Solutions Market by Disease Indication
11.2.7.1.4 Germany Cancer Pain Management Solutions Market by End Use
11.2.7.2 France Cancer Pain Management Solutions Market
11.2.7.2.1 France Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.2.2 France Cancer Pain Management Solutions Market by Treatment Type
11.2.7.2.3 France Cancer Pain Management Solutions Market by Disease Indication
11.2.7.2.4 France Cancer Pain Management Solutions Market by End Use
11.2.7.3 Italy Cancer Pain Management Solutions Market
11.2.7.3.1 Italy Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.3.2 Italy Cancer Pain Management Solutions Market by Treatment Type
11.2.7.3.3 Italy Cancer Pain Management Solutions Market by Disease Indication
11.2.7.3.4 Italy Cancer Pain Management Solutions Market by End Use
11.2.7.4 Spain Cancer Pain Management Solutions Market
11.2.7.4.1 Spain Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.4.2 Spain Cancer Pain Management Solutions Market by Treatment Type
11.2.7.4.3 Spain Cancer Pain Management Solutions Market by Disease Indication
11.2.7.4.4 Spain Cancer Pain Management Solutions Market by End Use
11.2.7.5 United Kingdom Cancer Pain Management Solutions Market
11.2.7.5.1 United Kingdom Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.5.2 United Kingdom Cancer Pain Management Solutions Market by Treatment Type
11.2.7.5.3 United Kingdom Cancer Pain Management Solutions Market by Disease Indication
11.2.7.5.4 United Kingdom Cancer Pain Management Solutions Market by End Use
11.2.7.6 Rest of Europe Cancer Pain Management Solutions Market
11.2.7.6.1 Rest of Europe Cancer Pain Management Solutions Market by Pain Management Type
11.2.7.6.2 Rest of Europe Cancer Pain Management Solutions Market by Treatment Type
11.2.7.6.3 Rest of Europe Cancer Pain Management Solutions Market by Disease Indication
11.2.7.6.4 Rest of Europe Cancer Pain Management Solutions Market by End Use
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Cancer Pain Management Solutions Market Overview
11.3.2 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis
11.3.3 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis - By Pain Management Type
11.3.4 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis - By Treatment Type
11.3.5 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis - By Disease Indication
11.3.6 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis - By End Use
11.3.7 Asia-Pacific Cancer Pain Management Solutions Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Cancer Pain Management Solutions Market
11.3.7.1.1 Australia Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.1.2 Australia Cancer Pain Management Solutions Market by Treatment Type
11.3.7.1.3 Australia Cancer Pain Management Solutions Market by Disease Indication
11.3.7.1.4 Australia Cancer Pain Management Solutions Market by End Use
11.3.7.2 China Cancer Pain Management Solutions Market
11.3.7.2.1 China Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.2.2 China Cancer Pain Management Solutions Market by Treatment Type
11.3.7.2.3 China Cancer Pain Management Solutions Market by Disease Indication
11.3.7.2.4 China Cancer Pain Management Solutions Market by End Use
11.3.7.3 India Cancer Pain Management Solutions Market
11.3.7.3.1 India Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.3.2 India Cancer Pain Management Solutions Market by Treatment Type
11.3.7.3.3 India Cancer Pain Management Solutions Market by Disease Indication
11.3.7.3.4 India Cancer Pain Management Solutions Market by End Use
11.3.7.4 Japan Cancer Pain Management Solutions Market
11.3.7.4.1 Japan Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.4.2 Japan Cancer Pain Management Solutions Market by Treatment Type
11.3.7.4.3 Japan Cancer Pain Management Solutions Market by Disease Indication
11.3.7.4.4 Japan Cancer Pain Management Solutions Market by End Use
11.3.7.5 South Korea Cancer Pain Management Solutions Market
11.3.7.5.1 South Korea Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.5.2 South Korea Cancer Pain Management Solutions Market by Treatment Type
11.3.7.5.3 South Korea Cancer Pain Management Solutions Market by Disease Indication
11.3.7.5.4 South Korea Cancer Pain Management Solutions Market by End Use
11.3.7.6 Rest of Asia-Pacific Cancer Pain Management Solutions Market
11.3.7.6.1 Rest of Asia-Pacific Cancer Pain Management Solutions Market by Pain Management Type
11.3.7.6.2 Rest of Asia-Pacific Cancer Pain Management Solutions Market by Treatment Type
11.3.7.6.3 Rest of Asia-Pacific Cancer Pain Management Solutions Market by Disease Indication
11.3.7.6.4 Rest of Asia-Pacific Cancer Pain Management Solutions Market by End Use
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Cancer Pain Management Solutions Market Overview
11.4.2 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis
11.4.3 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis - By Pain Management Type
11.4.4 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis - By Treatment Type
11.4.5 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis - By Disease Indication
11.4.6 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis - By End Use
11.4.7 Middle East and Africa Cancer Pain Management Solutions Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Cancer Pain Management Solutions Market
11.4.7.1.1 South Africa Cancer Pain Management Solutions Market by Pain Management Type
11.4.7.1.2 South Africa Cancer Pain Management Solutions Market by Treatment Type
11.4.7.1.3 South Africa Cancer Pain Management Solutions Market by Disease Indication
11.4.7.1.4 South Africa Cancer Pain Management Solutions Market by End Use
11.4.7.2 Saudi Arabia Cancer Pain Management Solutions Market
11.4.7.2.1 Saudi Arabia Cancer Pain Management Solutions Market by Pain Management Type
11.4.7.2.2 Saudi Arabia Cancer Pain Management Solutions Market by Treatment Type
11.4.7.2.3 Saudi Arabia Cancer Pain Management Solutions Market by Disease Indication
11.4.7.2.4 Saudi Arabia Cancer Pain Management Solutions Market by End Use
11.4.7.3 U.A.E Cancer Pain Management Solutions Market
11.4.7.3.1 U.A.E Cancer Pain Management Solutions Market by Pain Management Type
11.4.7.3.2 U.A.E Cancer Pain Management Solutions Market by Treatment Type
11.4.7.3.3 U.A.E Cancer Pain Management Solutions Market by Disease Indication
11.4.7.3.4 U.A.E Cancer Pain Management Solutions Market by End Use
11.4.7.4 Rest of Middle East and Africa Cancer Pain Management Solutions Market
11.4.7.4.1 Rest of Middle East and Africa Cancer Pain Management Solutions Market by Pain Management Type
11.4.7.4.2 Rest of Middle East and Africa Cancer Pain Management Solutions Market by Treatment Type
11.4.7.4.3 Rest of Middle East and Africa Cancer Pain Management Solutions Market by Disease Indication
11.4.7.4.4 Rest of Middle East and Africa Cancer Pain Management Solutions Market by End Use
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Cancer Pain Management Solutions Market Overview
11.5.2 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis
11.5.3 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis - By Pain Management Type
11.5.4 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis - By Treatment Type
11.5.5 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis - By Disease Indication
11.5.6 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis - By End Use
11.5.7 South and Central America Cancer Pain Management Solutions Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Cancer Pain Management Solutions Market
11.5.7.1.1 Brazil Cancer Pain Management Solutions Market by Pain Management Type
11.5.7.1.2 Brazil Cancer Pain Management Solutions Market by Treatment Type
11.5.7.1.3 Brazil Cancer Pain Management Solutions Market by Disease Indication
11.5.7.1.4 Brazil Cancer Pain Management Solutions Market by End Use
11.5.7.2 Argentina Cancer Pain Management Solutions Market
11.5.7.2.1 Argentina Cancer Pain Management Solutions Market by Pain Management Type
11.5.7.2.2 Argentina Cancer Pain Management Solutions Market by Treatment Type
11.5.7.2.3 Argentina Cancer Pain Management Solutions Market by Disease Indication
11.5.7.2.4 Argentina Cancer Pain Management Solutions Market by End Use
11.5.7.3 Rest of South and Central America Cancer Pain Management Solutions Market
11.5.7.3.1 Rest of South and Central America Cancer Pain Management Solutions Market by Pain Management Type
11.5.7.3.2 Rest of South and Central America Cancer Pain Management Solutions Market by Treatment Type
11.5.7.3.3 Rest of South and Central America Cancer Pain Management Solutions Market by Disease Indication
11.5.7.3.4 Rest of South and Central America Cancer Pain Management Solutions Market by End Use
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANCER PAIN MANAGEMENT SOLUTIONS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. CANCER PAIN MANAGEMENT SOLUTIONS MARKET, KEY COMPANY PROFILES
14.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ELI LILLY
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PFIZER
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. JOHNSON AND JOHNSON
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. PURDUE PHARMA
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. ENDO PHARMACEUTICALS PLC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANCER PAIN MANAGEMENT SOLUTIONS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENT
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Eli Lilly.
3. Pfizer
4. Johnson & Johnson
5. Purdue Pharma
6. Endo Pharmaceuticals Plc.
7. Forest Laboratories Inc.
8. GlaxoSmithKline Plc.
9. F. Hoffmann-La Roche Ltd.
10. Baxter International Inc.
11. Valeant Pharmaceuticals International Inc.
12. Daiichi Sankyo Co., Ltd
13. Grnenthal Pharma GmbH & Co. KG
14. Hisamitsu Pharmaceutical Co., Inc
15. Insys Therapeutics, Inc
16. Mundipharma International Limited
17. Orexo AB
18. Aoxing Pharmaceutical Company, Inc
19. BioDelivery Sciences International, Inc.
TIPRE00022897
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking